Masimo Corporation (NASDAQ:MASI) Shares Purchased by TD Asset Management Inc

TD Asset Management Inc lifted its stake in Masimo Corporation (NASDAQ:MASI - Free Report) by 4.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 88,668 shares of the medical equipment provider's stock after purchasing an additional 4,028 shares during the quarter. TD Asset Management Inc owned about 0.16% of Masimo worth $14,772,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC raised its holdings in Masimo by 128.9% in the 1st quarter. Farther Finance Advisors LLC now owns 206 shares of the medical equipment provider's stock valued at $35,000 after buying an additional 116 shares during the period. NBC Securities Inc. acquired a new position in Masimo during the 1st quarter worth about $61,000. UMB Bank n.a. grew its position in Masimo by 134.0% in the 1st quarter. UMB Bank n.a. now owns 447 shares of the medical equipment provider's stock valued at $74,000 after acquiring an additional 256 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Masimo by 58.4% during the first quarter. GAMMA Investing LLC now owns 738 shares of the medical equipment provider's stock worth $123,000 after purchasing an additional 272 shares in the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S acquired a new position in shares of Masimo in the fourth quarter valued at approximately $163,000. Institutional investors and hedge funds own 85.96% of the company's stock.

Masimo Trading Up 0.1%

MASI traded up $0.16 during midday trading on Friday, hitting $153.95. The company's stock had a trading volume of 476,023 shares, compared to its average volume of 525,233. Masimo Corporation has a 52-week low of $101.61 and a 52-week high of $194.88. The firm has a 50-day moving average price of $162.81 and a two-hundred day moving average price of $165.43. The firm has a market cap of $8.35 billion, a P/E ratio of -16.79 and a beta of 1.21. The company has a current ratio of 2.17, a quick ratio of 1.62 and a debt-to-equity ratio of 0.67.

Masimo (NASDAQ:MASI - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The medical equipment provider reported $1.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.12. Masimo had a negative net margin of 25.06% and a positive return on equity of 22.56%. The company had revenue of $372.00 million during the quarter, compared to analysts' expectations of $367.79 million. During the same period in the previous year, the company earned $0.77 EPS. The business's quarterly revenue was down 24.5% compared to the same quarter last year. On average, research analysts anticipate that Masimo Corporation will post 4.1 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have recently weighed in on MASI. Wall Street Zen lowered Masimo from a "buy" rating to a "hold" rating in a research report on Friday, May 30th. Piper Sandler reaffirmed an "overweight" rating and issued a $200.00 target price (down previously from $215.00) on shares of Masimo in a report on Wednesday, May 7th. Raymond James Financial lowered their price target on shares of Masimo from $204.00 to $185.00 and set an "outperform" rating for the company in a report on Wednesday, May 7th. Needham & Company LLC restated a "hold" rating on shares of Masimo in a report on Thursday, April 10th. Finally, Wells Fargo & Company lowered their target price on shares of Masimo from $205.00 to $190.00 and set an "overweight" rating for the company in a research note on Wednesday, May 7th. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, Masimo currently has an average rating of "Moderate Buy" and a consensus price target of $191.60.

Insider Transactions at Masimo

In other news, COO Bilal Muhsin sold 10,000 shares of the business's stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $163.28, for a total value of $1,632,800.00. Following the completion of the sale, the chief operating officer owned 24,172 shares of the company's stock, valued at approximately $3,946,804.16. The trade was a 29.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 9.70% of the stock is owned by corporate insiders.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.